Phase III Study to Determine the Effect of Combining Chemotherapy with Surgery and Radiotherapy for Resectable Squamous Cell Carcinoma of the Head and Neck
Research committees
Publication Information Expand/Collapse
2000
The influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: secondary analysis of RTOG 85-03
1999
The influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: secondary analysis of RTOG 85-03
1997
DNA content parameters in advanced, resectable squamous cell carcinomas of the head and neck (SCCHN); analysis of INT 0034, a RTOG (8503)-administered head and neck cancer intergroup trial.
Radiotherapy (RT) versus chemotherapy (CT) followed by RT in resected and negative margins head and neck cancers (HNC). Intergroup study 0034.
1994
Chemotherapy as predictor of compliance.
The effect of perioperative blood transfusion on survival in head and neck cancer.
Surgical reporting instrument designed to improve outcome data in head and neck cancer trials.
1993
Implications of positive surgical margins.
Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: A comparative study using the Intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database.
Postoperative irradiation in head and neck cancer.
1992
Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on Intergroup study 0034.
The effect of peri-operative blood transfusion on survival in head and neck cancer.
Chemotherapy as predictor of compliance.
An association between DNA diploid tumors and margin negative surgical resections: Implications for adjuvant trials in patients with advanced, resectable squamous cell carcinomas of the head and neck (SCCHN).
Phase III study comparing sequential chemotherapy (CT) and radiotherapy (RT) to RT for resected and negative margins squamous cell carcinoma of the head and neck: Intergroup study #0034.
Unappreciated impact of potentially "curative" surgery (pcs) in multi-modality head and neck (h+n) trials upon sample size requirements.
Chemotherapy as predector of compliance.
Is a surgical resection leaving positive margins of benefit to the patient with locally-advanced squamous cell carcinoma of hte head and neck?
Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck. Report on intergroup study 0034.
1991
Development of surgical quality-control mechanisms in large scale prospective trials: Head & Neck Intergroup Report.
Do otolarynologist-head and neck surgeons and/or chemotherapy have a role in the treatment of head and neck cancer?
Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on intergroup study 0034.
Development of surgical quality-control mechanisms in large-scale prospective trials: Head and neck intergroup report.
1989
Combine therapy for resectable head and neck cancer: A phase III study.
1988
Development of surgical quality control mechanism in large scale prospective trials - A head and neck intergroup report.
Phase III study to determine the effect of combining chemotherapy with surgery and radiotherapy for resectable sqamous cell carcinom of the head and neck.
Adequacy of sample sizes: Head and Neck intergroup experience (RTOG, SWOG, ECOG, CALGB, NCOG, and SECSG).